Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2014
|
| gptkbp:ATCCode |
L04AA33
|
| gptkbp:CASNumber |
943609-66-3
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
gptkb:vedolizumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
Entyvio
|
| gptkbp:KEGGID |
D09913
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:mechanismOfAction |
integrin receptor antagonist
|
| gptkbp:MedlinePlusID |
a614040
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescribes |
adults
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2108508
DB09033 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea headache arthralgia upper respiratory tract infection |
| gptkbp:UNII |
6B4YK2V4FK
|
| gptkbp:usedFor |
gptkb:Crohn's_disease
ulcerative colitis |
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|